Parp inhibitors in ovarian cancer: where are we now?

 

Authors

  • Vanda Salutari Gynecology Oncology Unit Università Cattolica del Sacro Cuore of Rome, Rome, Italy
  • Giovanni Scambia Gynecology Oncology Unit Università Cattolica del Sacro Cuore of Rome, Rome, Italy

Abstract

No abstract available

Downloads

Published

2014-04-15

How to Cite

1.
Salutari V, Scambia G. Parp inhibitors in ovarian cancer: where are we now?  . CBN [Internet]. 2014 Apr. 15 [cited 2024 Dec. 26];2(1):38-9. Available from: https://journals.aboutscience.eu/index.php/cancerbreakingnews/article/view/265

Issue

Vol. 2 No. 1 (2014): April 2014

Section

Letter to the Editor

License

Articles published in Cancer Breaking News are distributed under the CC Attribution-NonCommercial-NoDerivatives 4.0 license, which allows third parties to copy and redistribute the material providing appropriate credit and a link to the license but does not allow to use the material for commercial purposes and to use the material if it has been remixed, transformed or built upon.